ALMKT:EPA
Mauna Kea Technologies SA
€0.091
arrow_downward
-1.62%(-0.0015) 1 天
11月6日, GMT+1 17:35:04 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 ALMKT 生成关键数据洞见…
开盘价
€0.08
最高价
€0.09
最低价
€0.08
市值
1779.06万
平均成交量
54.95万
成交量
38.56万
市盈率
0.78
52 周最高价
€0.23
52 周最低价
€0.07
每股收益
€0.12
流通股数
1.95亿
员工人数
56
开盘价
€0.08
最高价
€0.09
最低价
€0.08
市值
1779.06万
平均成交量
54.95万
成交量
38.56万
市盈率
0.78
52 周最高价
€0.23
52 周最低价
€0.07
每股收益
€0.12
流通股数
1.95亿
员工人数
56
新闻报道
来自网络来源和新闻合作伙伴
TradingView
·
2天前
分析：比特币与标普500指数十年来相关性不断增强
UA.NEWS
·
1天前
AI股票遭抛售后，纳斯达克上涨1.23%——BBC News
TradingKey
·
1天前
标普500五个月几乎零涨幅：估值降至18.5倍，美股正在变便宜吗？
Longbridge
·
22小时前
【谋周记】闪电专挑暴雨天，暴跌之后怎么办（2026 年第45 周｜总第295 期）｜长桥证券
资料
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA简介